PolyPid (PYPD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $129.92M
Last updated: Nov 17, 2026 at 4:34 PM ET
PolyPid (PYPD) Statistics
PolyPid (PYPD) has a market cap of $129.92M. Its share count is up 18.07% from a year earlier.
Total Valuation
| Market Cap | $129.92M |
|---|---|
| Latest price (Nov 17, 2026) | $6.54 |
Key Dates
The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 11, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| Forward P/S | 11.5x |
|---|---|
| P/B Ratio | 39.7x |
Price Statistics
The stock is up 82.17% over 52 weeks and trades 20.89% above its 50-day average.
| Beta (1Y) | 0.84 |
|---|---|
| 52-Week Change | +82.17% |
| 1-Month Change | +34.02% |
| 3-Month Change | +30.54% |
| 6-Month Change | +37.40% |
| 5-Year Change | -97.48% |
| Total Return (1Y) | +82.17% |
| Total Return (3Y CAGR) | +18.80% |
| Total Return (5Y CAGR) | -50.48% |
| Return vs SPY (1Y) | +68.11% |
| Max Drawdown (1Y) | -32.97% |
| Max Drawdown (3Y) | -68.99% |
| Sharpe Ratio (1Y) | 1.00 |
| Correlation with SPY (1Y) | 0.20 |
| 50-Day Average | $5.41 |
| 200-Day Average | $4.81 |
| 52-Week Range | $3.50 to $7.15 |
| RSI (14 Days) | 66.7 |
| Average Volume (20 Days) | 207.75K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 5.94x current liabilities.
| Current Ratio | 5.94x |
|---|---|
| Quick Ratio | 5.66x |
Returns and Efficiency
Return on equity is -764.01% and return on assets is -74.29% over the last 12 months.
| Return on Equity (ROE) | -764.01% |
|---|---|
| Return on Assets (ROA) | -74.29% |
Scores
PYPD has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | $149.00K |
| Pretax Income | -$29.88M |
| Net Income | -$29.80M |
| Reported EPS (TTM) | -$1.35 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 9.72% of the $40.12M in total assets.
| Cash and Equivalents | $5.62M |
|---|---|
| Working Capital | $27.58M |
| Shareholder Equity | $3.90M |
| Book Value Per Share | $0.16 |
| Total Assets | $40.12M |
| Total Liabilities | $36.22M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Capital Expenditures | $0 |
|---|---|
| FCF Per Share | -$2.83 |
Trailing 12 months through Sep 30, 2026.
Stock Splits
The last split was a 1-for-30 reverse split on Sep 21, 2023.
| Last Split Date | Sep 21, 2023 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:30 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PYPD
What is PYPD's market cap?
PolyPid has a market cap of $129.92M.
How many shares of PYPD are outstanding?
PolyPid has 23.68M shares outstanding. The count is up 18.07% from a year earlier.
Does PYPD pay a dividend?
No. PolyPid does not pay a dividend.
PYPD pages: Overview, Charting, Earnings, Forecast, Statistics, Competitors